de Dodge & Cox Boston Scientific BSX Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 3.73 M | Vender |
87,485
-1,400
| -2% | -USD 76 k | ﹤0.01% | 149 |
|
|
2026
Q1 | USD 5.58 M | Mantener |
88,885
| – | – | ﹤0.01% | 138 |
|
|
2025
Q4 | USD 8.48 M | Mantener |
88,885
| – | – | ﹤0.01% | 130 |
|
|
2025
Q3 | USD 8.68 M | Vender |
88,885
-1,500
| -2% | -USD 155 k | ﹤0.01% | 129 |
|
|
2025
Q2 | USD 9.7 M | Vender |
90,385
-1,310
| -1% | -USD 133 k | 0.01% | 126 |
|
|
2025
Q1 | USD 9.25 M | Vender |
91,695
-3,100
| -3% | -USD 312 k | 0.01% | 121 |
|
|
2024
Q4 | USD 8.47 M | Vender |
94,795
-500
| -0.5% | -USD 44 k | ﹤0.01% | 123 |
|
|
2024
Q3 | USD 7.99 M | Vender |
95,295
-1,800
| -2% | -USD 142 k | ﹤0.01% | 122 |
|
|
2024
Q2 | USD 7.48 M | Mantener |
97,095
| – | – | ﹤0.01% | 121 |
|
|
2024
Q1 | USD 6.65 M | Mantener |
97,095
| – | – | ﹤0.01% | 122 |
|
|
2023
Q4 | USD 5.61 M | Vender |
97,095
-10
| -0% | -USD 534 | ﹤0.01% | 126 |
|
|
2023
Q3 | USD 5.13 M | Vender |
97,105
-1,775
| -2% | -USD 93.1 k | ﹤0.01% | 122 |
|
|
2023
Q2 | USD 5.35 M | Vender |
98,880
-6,710
| -6% | -USD 350 k | ﹤0.01% | 119 |
|
|
2023
Q1 | USD 5.28 M | Vender |
105,590
-7,300
| -6% | -USD 344 k | ﹤0.01% | 120 |
|
|
2022
Q4 | USD 5.22 M | Vender |
112,890
-2,700
| -2% | -USD 117 k | ﹤0.01% | 120 |
|
|
2022
Q3 | USD 4.48 M | Vender |
115,590
-5,000
| -4% | -USD 201 k | ﹤0.01% | 124 |
|
|
2022
Q2 | USD 4.49 M | Mantener |
120,590
| – | – | ﹤0.01% | 122 |
|
|
2022
Q1 | USD 5.34 M | Vender |
120,590
-5,000
| -4% | -USD 217 k | ﹤0.01% | 120 |
|
|
2021
Q4 | USD 5.34 M | Vender |
125,590
-4,500
| -3% | -USD 189 k | ﹤0.01% | 118 |
|
|
2021
Q3 | USD 5.64 M | Mantener |
130,090
| – | – | ﹤0.01% | 110 |
|
|
2021
Q2 | USD 5.56 M | Vender |
130,090
-1,200
| -0.9% | -USD 50.5 k | ﹤0.01% | 110 |
|
|
2021
Q1 | USD 5.07 M | Vender |
131,290
-1,700
| -1% | -USD 64.3 k | ﹤0.01% | 110 |
|
|
2020
Q4 | USD 4.78 M | Vender |
132,990
-5,000
| -4% | -USD 180 k | ﹤0.01% | 110 |
|
|
2020
Q3 | USD 5.27 M | Vender |
137,990
-5,100
| -4% | -USD 197 k | ﹤0.01% | 109 |
|
|
2020
Q2 | USD 5.02 M | Vender |
143,090
-21,750
| -13% | -USD 783 k | ﹤0.01% | 107 |
|
|
2020
Q1 | USD 5.38 M | Vender |
164,840
-9,600
| -6% | -USD 375 k | 0.01% | 98 |
|
|
2019
Q4 | USD 7.89 M | Vender |
174,440
-200
| -0.1% | -USD 8.37 k | 0.01% | 99 |
|
|
2019
Q3 | USD 7.11 M | Vender |
174,640
-2,000
| -1% | -USD 84.7 k | 0.01% | 99 |
|
|
2019
Q2 | USD 7.59 M | Vender |
176,640
-105
| -0.1% | -USD 4.04 k | 0.01% | 101 |
|
|
2019
Q1 | USD 6.78 M | Vender |
176,745
-20,065
| -10% | -USD 766 k | 0.01% | 106 |
|
|
2018
Q4 | USD 6.96 M | Vender |
196,810
-7,445
| -4% | -USD 270 k | 0.01% | 106 |
|
|
2018
Q3 | USD 7.86 M | Vender |
204,255
-7,700
| -4% | -USD 269 k | 0.01% | 105 |
|
|
2018
Q2 | USD 6.93 M | Vender |
211,955
-26,400
| -11% | -USD 796 k | 0.01% | 102 |
|
|
2018
Q1 | USD 6.51 M | Vender |
238,355
-15,000
| -6% | -USD 408 k | 0.01% | 101 |
|
|
2017
Q4 | USD 6.28 M | Vender |
253,355
-49,000
| -16% | -USD 1.35 M | ﹤0.01% | 103 |
|
|
2017
Q3 | USD 8.82 M | Vender |
302,355
-21,900
| -7% | -USD 605 k | 0.01% | 100 |
|
|
2017
Q2 | USD 8.99 M | Vender |
324,255
-4,400
| -1% | -USD 117 k | 0.01% | 96 |
|
|
2017
Q1 | USD 8.17 M | Vender |
328,655
-43,016
| -12% | -USD 1.05 M | 0.01% | 98 |
|
|
2016
Q4 | USD 8.04 M | Vender |
371,671
-10,459
| -3% | -USD 228 k | 0.01% | 99 |
|
|
2016
Q3 | USD 9.1 M | Vender |
382,130
-2,800
| -0.7% | -USD 66.8 k | 0.01% | 96 |
|
|
2016
Q2 | USD 9 M | Vender |
384,930
-42,500
| -10% | -USD 919 k | 0.01% | 95 |
|
|
2016
Q1 | USD 8.04 M | Vender |
427,430
-23,400
| -5% | -USD 411 k | 0.01% | 96 |
|
|
2015
Q4 | USD 8.31 M | Vender |
450,830
-22,130
| -5% | -USD 397 k | 0.01% | 99 |
|
|
2015
Q3 | USD 7.76 M | Vender |
472,960
-115,300
| -20% | -USD 1.97 M | 0.01% | 93 |
|
|
2015
Q2 | USD 10.4 M | Vender |
588,260
-141,200
| -19% | -USD 2.52 M | 0.01% | 88 |
|
|
2015
Q1 | USD 12.9 M | Vender |
729,460
-455,270
| -38% | -USD 7.2 M | 0.01% | 87 |
|
|
2014
Q4 | USD 15.7 M | Vender |
1,184,730
-43,273,608
| -97% | -USD 553 M | 0.01% | 86 |
|
|
2014
Q3 | USD 525 M | Vender |
44,458,338
-414,480
| -0.9% | -USD 5.22 M | 0.5% | 59 |
|
|
2014
Q2 | USD 573 M | Vender |
44,872,818
-351,350
| -0.8% | -USD 4.57 M | 0.55% | 55 |
|
|
2014
Q1 | USD 611 M | Vender |
45,224,168
-714,300
| -2% | -USD 9.38 M | 0.63% | 53 |
|
|
2013
Q4 | USD 552 M | Vender |
45,938,468
-13,218,639
| -22% | -USD 156 M | 0.58% | 56 |
|
|
2013
Q3 | USD 695 M | Vender |
59,157,107
-22,644,023
| -28% | -USD 245 M | 0.79% | 43 |
|
|
2013
Q2 | USD 758 M | Comprar |
+81,801,130
| Nuevas | +USD 694 M | 0.9% | 35 |
|
Otros fondos que tienen BSX en su cartera
Posición de Dodge & Cox en BSX: resumen de T2 2026
Dodge & Cox redujo su participación en Boston Scientific (BSX) en 1.6% durante T2 2026, al vender acciones por un valor estimado de USD 76 k, y conservó 87,485 acciones valuadas en USD 3.73 M. La posición representa ﹤0.01% de la cartera y ocupa el puesto #149.
Dodge & Cox reportó por primera vez una posición en BSX en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. La posición alcanzó su máximo de USD 758 M en T2 2013. Al cierre de T2 2026, 1,489 fondos que sigue Wall St. Rank mantienen una posición en BSX.
- Al cierre de T2 2026, Dodge & Cox tenía 87,485 acciones de Boston Scientific con un valor de USD 3.73 M.
- Dodge & Cox vendió 1,400 acciones de Boston Scientific en T2 2026, por un valor estimado de USD 76 k.
- Boston Scientific representó ﹤0.01% de la cartera de Dodge & Cox en T2 2026 y fue su posición número 149.
- Dodge & Cox reportó por primera vez una posición en Boston Scientific en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- La posición de Dodge & Cox en Boston Scientific alcanzó su máximo de USD 758 M en T2 2013.
- Al cierre de T2 2026, 1,489 fondos que sigue Wall St. Rank tenían Boston Scientific en cartera.
Según el Informe 13F de Dodge & Cox correspondiente a T2 2026, presentado el 13 ago 2026.